跳至主要内容
临床试验/NCT00713674
NCT00713674撤回不适用

Comparison of Decolonization of MRSA Using Theraworx

Mercy Research0 个研究点开始时间: 2008年3月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
撤回
主要终点
Evidence of decolonization confirmed by intranasal culture

研究概览

简要总结

The purpose of this study is to examine treatment method of Methicillin-resistant Staphylococcus aureus (MRSA) decolonization in patients.

详细描述

Decolonization therapy is indicated for management of patients with MRSA. Theraworx is reported to be an effective antimicrobial against multiple organisms. In this study, patients with positive MRSA colonization culture will be treated with Theraworx to evaluate decolonization duration capability.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Positive MRSA culture

排除标准

  • Patients currently on or start antibiotic therapy directed for MRSA.(Prophylaxis antibiotic for surgical procedure not considered therapy.)
  • Patients with MRSA infected wounds
  • Patients under the age of 18 years
  • A woman currently pregnant or nursing a child
  • Patients participating in another study within 30 days of randomization

研究组 & 干预措施

2

Experimental

Theraworx intranasal

干预措施: Theraworx (Other)

3

Active Comparator

mupirocin antibiotic ointment intranasal

干预措施: mupirocin antibiotic ointment (Drug)

结局指标

主要结局

Evidence of decolonization confirmed by intranasal culture

时间窗: Up to 14 days post treatment (+/- 1-2 days)

次要结局

  • Economic-Cost comparison of treatment Evidence of decolonization(5 days of treatment)

研究者

申办方类型
Other
责任方
Sponsor

相似试验